Hepatitis B: A new rapid diagnostic test to halt mother-to-child transmission
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...
BioSpace2 天
Arbutus Down to ‘Core Team’ After Laying Off More Than Half of Staff
Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The ...
eLife4 天
Induction of hepatitis B core protein aggregation targeting an unconventional binding site
Rudolf Virchow Center, Center for Integrative and Translational Bioimaging; University of Würzburg, Germany; Biocenter, University of Würzburg, Germany; ...
Fierce Biotech2 天
Arbutus jettisons 57% of staff, ceases in-house research
The restructuring is only the latest round of layoffs to hit Arbutus after the company shed 40% of its staff and cut back on ...
Arbutus Biopharma: A Wing And A Prayer
Arbutus Biopharma restructures to cut costs & focus on Hepatitis B drug imdusiran. Read more about ABUS stock here.
EurekAlert!5 天
Hepatitis B: new rapid diagnostic test to halt mother-to-child transmission
Hepatitis B is a liver inflammation caused by the hepatitis ... offers an innovative solution that detects "HBV core-related antigen", considered as a reliable marker of active infection, and ...
Fierce Biotech3 天
Ascletis slashes funding for former core programs in pivot to obesity
Responding to the progress of its obesity pipeline, the Chinese biotech is stepping up its investment in metabolic disease ...